Time course of changes in the list of drugs for the treatment of COVID-19 in the temporary guidelines
DOI: https://doi.org/10.29296/25877305-2021-11-06
Issue:
11
Year:
2021
To identify the features of treatment for coronavirus infection (COVID-19), the authors have
analyzed changes in the list of drugs and treatment regimens described in the temporary clinical guidelines.
Keywords:
infectious diseases
COVID-19
coronavirus infection
community-acquired pneumonia
drug provision
temporary clinical guidelines
References:
- Borodulina E.A., Shirobokov Ja.E., Gladunova E.P. i dr. Diagnostika i farmakoterapija virus-assotsiirovannyh porazhenij legkih. Klinicheskaja farmakologija i terapija. 2020; 29 (3): 61–6 [Borodulina E.A., Shirobokov Y.E., Gladunova E.P. et al. Virus-associated lung disease. Clinical pharmacology and therapy. 2020; 29 (3): 61–6 (in Russ.)]. DOI: 10.32756/0869-5490-2020-3-61-66
- Kudlaj D.A., Shirobokov Ja.E., Gladunova E.P. i dr. Diagnostika COVID-19. Sposoby i problemy obnaruzhenija virusa SARS-CoV-2 v uslovijah pandemii. Vrach. 2020; 31 (8): 5–10 [Kudlay D., Shirobokov Ya., Gladunova E. et al. Diagnosis of COVID-19. Methods and problems of virus SARS-CoV-2 detection under pandemic conditions. Vrach. 2020; 31 (8): 5–10 (in Russ.)]. https://doi.org/10.29296/25877305-2020-08-01
- Malkova A., Kudlay D., Kudryavtsev I. et al. Immunogenetic Predictors of Severe COVID-19. Vaccines. 2021; 9: 211. DOI: 10.3390/vaccines9030211
- Starshinova A.A., Kushnareva E.A., Kudlaj D.A. i dr. Vozmozhnosti lechenija bol'nyh s COVID-19: analiz dannyh literatury. Transljatsionnaja meditsina. 2020; 7 (3): 30–7 [Starshinova A.A., Kushnareva E.A., Kudlay D.A. et al. Prospects for a COVID-19 treatment: review. Translational Medicine. 2020; 7 (3): 30–7 (in Russ.)]. DOI: 10.18705/2311-4495-2020-7-3-30-37
- Gudima G.O., Haitov R.M., Kudlaj D.A. i dr. Molekuljarno-immunologicheskie aspekty diagnostiki, profilaktiki i lechenija koronavirusnoj infektsii. Immunologija. 2021; 42 (3): 198–210 [Gudima G.O., Khaitov R.M., Kudlay D.A. et al. Molecular immunological aspects of diagnostics, prevention and treatment of coronavirus infection. Immunologiya. 2021; 42 (3): 198–210 (in Russ.)]. DOI: 10.33029/0206-4952-2021-42-3-198-210
- Kozlov V.A., Savchenko A.A., Kudrjavtsev I.V. i dr. Klinicheskaja immunologija. Krasnojarsk: Polikor, 2020; 386 s. [Kozlov V.A., Savchenko A.A., Kudryavtsev I.V. et al. Klinicheskaya immunologiya. Krasnoyarsk: Polikor, 2020; 386 s. (in Russ.)]. DOI: 10.17513/np.438
- Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (2019-nCoV). Vremennye metodicheskie rekomendatsii. Versija 2 (03.02.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (2019-nCoV). Vremennye metodicheskie rekomendatsii. Versiya 2 (03.02.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
- Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (2019-nCoV). Vremennye metodicheskie rekomendatsii. Versija 3 (03.03.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (2019-nCoV). Vremennye metodicheskie rekomendatsii. Versiya 3 (03.03.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
- Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 4 (27.03.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 4 (27.03.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
- Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected. Interim guidance, 2020.
- Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 5 (08.04.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 5 (08.04.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
- Pogue J.M., Kaye K.S., Veve M. et al. 2406. «Real-world» Treatment of Multidrug-Resistant (MDR) or Extensively Drug-Resistant (XDR) P. aeruginosa Infections With Ceftolozane/Tazobactam (C/T) vs. a Polymyxin or Aminoglycoside (Poly/AG)-based Regimen: A Multicenter Comparative Effectiveness Study. Open Forum Infect Dis Oxford University Press (OUP). 2018; 5 (№ suppl. 1): S719–S719. DOI: 10.1093/ofid/ofy210.2059
- Karpova L.S., Sominina A.A., Dmitrieva M.N. i dr. Sravnitel'nyj analiz pandemii grippa a(H1N1)pdm09 v Rossii (2009–2010 gg.) i posledujuschih epidemij (2011–2014 gg.). Epidemiologija i vaktsinoprofilaktika. 2014; 6 (79): 8–16 [Karpova L.S., Sominina A.A., Dmitrieva M.N. et al. Sravnitel’nyi analiz pandemii grippa a(H1N1)pdm09 v Rossii (2009–2010 gg.) i posleduyushchikh epidemii (2011–2014 gg.). Epidemiologiya i vaktsinoprofilaktika. 2014; 6 (79): 8–16 (in Russ.)].
- Stovba L.F., Lebedev V.N., Petrov A.A. i dr. Novyj koronavirus, vyzyvajuschij zabolevanie cheloveka. Problemy osobo opasnyh infektsij. 2015; 2: 68–74 [Stovba L.F., Lebedev V.N., Petrov A.A. et al. Emerging Coronavirus Which Gives Rise to the Disease in Humans. Problems of Particularly Dangerous Infections. 2015; 2: 68–74 (in Russ.)]. DOI: 10.21055/0370-1069-2015-2-68-74
- Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 6 (24.04.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 6 (24.04.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
- Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 7 (03.06.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 7 (03.06.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
- Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 8.1 (01.10.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 8.1 (01.10.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
- Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 8 (03.09.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 8 (03.09.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
- Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 9 (26.10.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 9 (26.10.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
- Profilaktika, diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 10 (08.02.2020). M.: Minzdrav Rossii, 2021 [Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 10 (08.02.2020). M.: Minzdrav Rossii, 2021 (in Russ.)].
- Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 11 (07.05.2021). M.: Minzdrav Rossii, 2021 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 11 (07.05.2021). M.: Minzdrav Rossii, 2021 (in Russ.)].
- Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 12 (21.09.2021). M.: Minzdrav Rossii, 2021 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 12 (21.09.2021). M.: Minzdrav Rossii, 2021 (in Russ.)].
- Ministerstvo zdravoohranenija Rossijskoj Federatsii. Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 13 (14.10.2021). M.: Minzdrav Rossii, 2021 [Ministerstvo zdravookhraneniya Rossiiskoi Federatsii. Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 13 (14.10.2021). M.: Minzdrav Rossii, 2021 (in Russ.)].
- Tang Y., Liu J., Zhang D. et al. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies. Front Immunol. 2020; 11: 1708. DOI: 10.3389/fimmu.2020.01708
- Coomes E.A., Haghbayan H. Interleukin-6 in Covid-19: A systematic review and meta-analysis. Rev Med Virol. 2020; 30 (6): 1–9. DOI: 10.1002/rmv.2141
- Asakura H., Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021; 113 (1): 45–57. DOI: 10.1007/s12185-020-03029-y
- Luo L., Xu M., Du M. et al. Early coagulation tests predict risk stratification and prognosis of COVID-19. Aging (Albany NY). 2020; 12 (16): 15918–37. DOI: 10.18632/aging.103581
- Hunt B.J., De Paula E. V., McLintock C. et al. Prophylactic anticoagulation for patients in hospital with COVID-19. BMJ. 2021; 372: n487. DOI: 10.1136/bmj.n487
- Horby P., Lim W.S., Emberson J.R. et al. RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021; 384 (8): 693–704. DOI: 10.1056/NEJMoa2021436
- Sterne J.A.C. et al. Association between Administration of Systemic Corticosteroids and Mortality among Critically Ill Patients with COVID-19: A Meta-analysis. JAMA. 2020; 324 (13): 1330–41. DOI: 10.1001/jama.2020.17023